DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Tesch H, Stoetzer O, Decker T. et al.
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial.

Int J Cancer 2019;
144: 877-885

Download Bibliographical Data

Search in:
Access: